Trombose venosa extensa com acometimento maciço das câmaras cardíacas direitas: relato de caso
DOI:
https://doi.org/10.34119/bjhrv7n2-248Keywords:
trombose venosa, tromboembolismo pulmonar, neoplasia maligna, câmaras cardíacas direitasAbstract
A trombose venosa está relacionada a neoplasias e, em muitos casos, pode ser a única manifestação da malignidade. Relatamos o caso de uma paciente recém diagnosticada com neoplasia uterina em que houve o diagnóstico de trombose maciça acometendo até as câmaras cardíacas direitas. A paciente foi tratada por método cirúrgico, com boa evolução pós-operatória. As decisões terapêuticas em casos semelhantes devem ser individualizadas, uma vez que não há evidências e recomendações sólidas em diretrizes.
References
Renni MJP, Cerqueira MH, Trugilho IA, Araujo Jr MLC, Marques MA, Koch HA. Mecanismos do tromboembolismo venoso no câncer: uma revisão da literatura. J Vasc Bras. 2017;16(4):308–13.
Goldhaber SZ. Risk Factors for Venous Thromboembolism. Journal of the American College of Cardiology. 2010 Jun;56(1):1–7.
Mulder FI, Horvàth-Puhó E, van Es N, van Laarhoven H, Pedersen L, Moik F, et al. Venous thromboembolism in cancer patients: a population-based cohort study. Blood. 2020 Nov 10.
Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003;107(23 Suppl 1):I17-21.
Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846-50.
Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60-8.
Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based casecontrol study. Arch Intern Med. 2000;160(6):809-15.
Iodice S, Gandini S, Löhr M, Lowenfels MAB, Maisonneuve P. Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost. 2008 May;6(5):781-8.
Abdol Razak N, Jones G, Bhandari M, Berndt M, Metharom P. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers (Basel). 2018 Oct 11;10(10):380.
Yuan Bin Yu, Jyh Pyng Gau, Chun Yu Liu, Muh Hwa Yang, Shu Chiung Chiang, Hsu H, et al. A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost. 2012 Jan 1;108(08):225–35.
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood. 2008 May 15;111(10):4902–7.
Walker AJ, Card TR, West J, Crooks C, Grainge MJ. Incidence of venous thromboembolism in patients with cancer – A cohort study using linked United Kingdom databases. European Journal of Cancer. 2013 Apr;49(6):1404–13.
Moik F, Ay C, Pabinger I. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future. Thrombosis Research. 2020 Jul;191:S3–11.
Hisada Y, Mackman N. Cancer-associated pathways and biomarkers of venous thrombosis. Blood. 2017 Sep 28;130(13):1499–506.
Theophanous RG, Chow VW, Convissar DL, Haskins SC, Jones RA, P Kalagara HK, et al. Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis. J Vis Exp. 2023 Feb 10:(192).
Varrias D, Palaiodimos L,Balasubramanian P, Barrera CA, Nauka P, Melainis AA, et al. The Use of Point-of-Care Ultrasound (POCUS) in the Diagnosis of Deep Vein Thrombosis J Clin Med. 2021 Sep; 10(17): 3903.
De Almeida MJ, Guillaumon AT, Miquelin D, Joviliano EE, Hafner L, Sobreira ML, et al. Diretrizes de conceito, diagnóstico e tratamento da trombose venosa superficial. J Vasc Bras. 2019;18:e20180105.
Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, et al. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). J Clin Oncol. 2018 Jul 10;36(20):2017-2023.
Kahale LA, Hakoum MB, Tsolakian IG, Alturki F, Matar CF, Terrenato I, et al. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer. Cochrane Database Syst Rev. 2018 Jun 19;6(6):CD006650.
Kakkos SK, Kirkilesis GI, Tsolakis IA. Editor’s Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Eur J Vasc Endovasc Surg. 2014;48(5):565-75.
